NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Tuesday that second-quarter revenues increased 3 percent year over year, helped along by a $1.4 million contribution from its eBioscience acquisition.

For the three months ended June 30, revenues for the Santa Clara, Calif.-based microarray firm increased to $66.4 million, up from $64.7 million in the year-ago period. The results beat the average analyst estimate of $65.6 million.